These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10753945)

  • 21. Prostaglandin E2 stimulates p53 transactivational activity through specific serine 15 phosphorylation in human synovial fibroblasts. Role in suppression of c/EBP/NF-kappaB-mediated MEKK1-induced MMP-1 expression.
    Faour WH; He Q; Mancini A; Jovanovic D; Antoniou J; Di Battista JA
    J Biol Chem; 2006 Jul; 281(29):19849-60. PubMed ID: 16714289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase.
    Ravanti L; Häkkinen L; Larjava H; Saarialho-Kere U; Foschi M; Han J; Kähäri VM
    J Biol Chem; 1999 Dec; 274(52):37292-300. PubMed ID: 10601295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel p53/microRNA-22/Cyr61 axis in synovial cells regulates inflammation in rheumatoid arthritis.
    Lin J; Huo R; Xiao L; Zhu X; Xie J; Sun S; He Y; Zhang J; Sun Y; Zhou Z; Wu P; Shen B; Li D; Li N
    Arthritis Rheumatol; 2014 Jan; 66(1):49-59. PubMed ID: 24449575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of mouse thymidylate synthase promoter activity by the wild-type p53 tumor suppressor protein.
    Lee Y; Chen Y; Chang LS; Johnson LF
    Exp Cell Res; 1997 Aug; 234(2):270-6. PubMed ID: 9260894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.
    Zalcenstein A; Stambolsky P; Weisz L; Müller M; Wallach D; Goncharov TM; Krammer PH; Rotter V; Oren M
    Oncogene; 2003 Aug; 22(36):5667-76. PubMed ID: 12944915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of synoviocyte proliferation, apoptosis, and invasion by the p53 tumor suppressor gene.
    Aupperle KR; Boyle DL; Hendrix M; Seftor EA; Zvaifler NJ; Barbosa M; Firestein GS
    Am J Pathol; 1998 Apr; 152(4):1091-8. PubMed ID: 9546370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
    Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
    Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human metalloproteinase-1 (collagenase-1) is a tumor suppressor protein p53 target gene.
    Sun Y; Sun Y; Wenger L; Rutter JL; Brinckerhoff CE; Cheung HS
    Ann N Y Acad Sci; 1999 Jun; 878():638-41. PubMed ID: 10415795
    [No Abstract]   [Full Text] [Related]  

  • 29. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
    Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
    Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follistatin-like protein 1 induction of matrix metalloproteinase 1, 3 and 13 gene expression in rheumatoid arthritis synoviocytes requires MAPK, JAK/STAT3 and NF-κB pathways.
    Ni S; Li C; Xu N; Liu X; Wang W; Chen W; Wang Y; van Wijnen AJ
    J Cell Physiol; 2018 Jan; 234(1):454-463. PubMed ID: 29932210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation of collagenase 3 expression in synovial fibroblasts of patients with rheumatoid arthritis by contact with a three-dimensional collagen matrix or with normal cartilage when coimplanted in NOD/SCID mice.
    Wernicke D; Schulze-Westhoff C; Bräuer R; Petrow P; Zacher J; Gay S; Gromnica-Ihle E
    Arthritis Rheum; 2002 Jan; 46(1):64-74. PubMed ID: 11817610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.
    Werner H; Karnieli E; Rauscher FJ; LeRoith D
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8318-23. PubMed ID: 8710868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
    Li B; Lee MY
    J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor.
    Aho S; Rouda S; Kennedy SH; Qin H; Tan EM
    Eur J Biochem; 1997 Jul; 247(2):503-10. PubMed ID: 9266691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repression of human reduced folate carrier gene expression by wild type p53.
    Ding BC; Whetstine JR; Witt TL; Schuetz JD; Matherly LH
    J Biol Chem; 2001 Mar; 276(12):8713-9. PubMed ID: 11106643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y.
    Matsui T; Katsuno Y; Inoue T; Fujita F; Joh T; Niida H; Murakami H; Itoh M; Nakanishi M
    J Biol Chem; 2004 Jun; 279(24):25093-100. PubMed ID: 15044452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades.
    Gum R; Wang H; Lengyel E; Juarez J; Boyd D
    Oncogene; 1997 Mar; 14(12):1481-93. PubMed ID: 9136992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.